Back to News
Market Impact: 0.4
AMGN Q3 Earnings Call Highlights Pipeline and Raised Outlook
Source: zacks.com
Corporate EarningsCorporate Guidance & OutlookHealthcare & BiotechCompany Fundamentals
Amgen raised its 2026 outlook after Q3 earnings and revenue exceeded estimates. The company cited progress with IMDELLTRA and MariTide's potential as long-term growth opportunities.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
AMGN0.80
More News
- UBS raises Amgen stock price target to $530 on diversification
- Stocks Surged Across the Board Today, and Biotech Brought Its Own Earnings Story
- Truist raises Amgen stock price target on earnings beat
- Reed Jobs’s Yosemite raises $350 million second fund to make cancer non-lethal
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Voters rebuff data centers in every ballot measure except one during the 2026 midterms